In view of the important role of the MAPKs/ERK and PI3K/AKT pathways in the occurrence of hematologic malignant diseases, we further detected the changes in pERK and pAKT of erythroblasts at day17 between individuals in the normal group and MDS patients with different stratifications. The gene discussed is AKT1; the disease is myelodysplastic syndrome.